The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice With Experimental Colitis

Journal of Clinical Immunology - United States
doi 10.1007/s10875-007-9074-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC